However, in individuals with mild dementia and longer life expectancies, the potential benefits could be significant and the person should not be denied them based on the 'dementia' label.

Nov. 6, 2024 — Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a new ...

Dementia treatment is more than just medication. It can include lifestyle changes, multimodal therapy, and environmental management, as well. Your dementia treatment plan will depend on underlying ...

A compassionate, multidisciplinary approach can help manage one of the most complex challenges nursing homes and other long-term care providers face.

The daughters of a Colorado Springs couple are alleging that a homeless woman, her boyfriend and her son have taken advantage of their father, who suffers from dementia, and taken over their ...

Dementia, a degenerative disorder affecting ... Make sure to read the label and follow the recommended dosage instructions. The quality of a supplement can vary greatly depending on the manufacturer.

It’s estimated that at least 4.3 million people 55 or older in the United States with cognitive impairment or dementia live alone ... Francisco she visited at home for a research project ...

People living with dementia are less likely to be admitted to high-rated nursing homes compared to people who don’t have the disease, a new study finds. Researchers looked at admission to ...

A new diagnosis of Alzheimer's or other dementia often spurs a person to move from their home, new research shows. "One possible explanation is that individuals with dementia and their caregivers ...

Research shows there are more than 944,000 people in the UK who have dementia. 1 in 11 people over the age of 65 have dementia in the UK.There are two key symptoms to be aware of and it has a ...

Celebrities including Queen Letizia stun in a dress that saved Victoria Beckham's eponymous fashion line, a calf length dress ...

Reported last patient, last visit in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with early-stage dementia with Lewy bodies ... to continue in the study while receiving ...